Back

The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

1 September 2024 (12:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Platelets and thrombosis: novel experimental aspects Cardiac Biology and Physiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Thomas Pirker

Christchurch (New Zealand)

4 More presentations in this session

Presentation thumbnail
Sphingosine-1-phosphate reduces arterial thrombosis via enhanced endothelial thrombomodulin expression by S1PR1 signaling
Doctor M. Benkhoff (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia
Doctor S. Kuehne (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Thrombin generation, fibrin clot permeation and lysis in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair: mitral fibrin study.
Doctor A. Siniarski (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation
Doctor S. Ministrini (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Platelets and thrombosis: novel experimental aspects

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Activation of AMPK via inhibition of PAR2 limits myocardial ischemia-reperfusion injury
thumbnail
Congress Presentation
Novel first-in-class drug candidate protects from ischemia-reperfusion injury by targeting the SERCA2 complex
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources